Company Filing History:
Years Active: 2009
Title: The Innovations of Jonathan Reeves
Introduction
Jonathan Reeves is a notable inventor based in Hawkesbury, Canada. He has made significant contributions to the field of diagnostic reagents and assays, particularly in relation to prostate cancer. His work has the potential to improve the evaluation and prognosis of this serious disease.
Latest Patents
Jonathan Reeves holds a patent for PSP94 diagnostic reagents and assays. This patent focuses on the detection of PSP94 in serum, where it can exist in both free and bound forms. The bound form of PSP94 has been quantified in the blood of prostate cancer patients, demonstrating its utility in evaluating and predicting the progression of prostate cancer. The patent includes diagnostic assays, methods, and kits for detecting the free form of PSP94, along with reagents such as antibodies that can bind to it.
Career Highlights
Jonathan is currently employed at Ambrilia Biopharma, Inc., where he continues to advance his research in the field of diagnostics. His innovative work has garnered attention for its potential impact on cancer diagnostics and patient care.
Collaborations
He collaborates with esteemed colleagues, including Edward Jerome Tanner and Chandra J Panchal, who contribute to the research and development efforts at Ambrilia Biopharma, Inc.
Conclusion
Jonathan Reeves is a pioneering inventor whose work in diagnostic reagents is making strides in the fight against prostate cancer. His contributions are vital for enhancing diagnostic methods and improving patient outcomes.